[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.204.137.239. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
March 20, 2002

Partnerships Between Universities and Industry

Author Affiliations
 

Stephen J.LurieMD, PhD, Senior EditorIndividualAuthor

JAMA. 2002;287(11):1398-1400. doi:10.1001/jama.287.11.1395

To the Editor: Drs Gelijns and Thier1 argue that the relationship between university and industry should be reconsidered by "balancing risks against benefits" and then, in an apparent contradiction, urge university and industry "to maximize the upsides of collaboration and minimize the downsides," a premise they adopt by disregarding several substantive conflicts of interest. For example, the past decade has seen a growing number of university presidents and medical leaders who accept appointments to health-related corporate boards of directors, thus assuming fiduciary responsibilities on behalf of their stockholders. This role is in direct conflict with student and patient welfare and the overall mission of the university, not to mention the message it sends to faculty, researchers, and physicians. Angell2 asks, "How can they [academic medical institutions] justify rigorous conflict-of-interest policies for individual researchers when their own ties are so extensive?" She also warns, "The incentives of the market-place should not become woven into the fabric of academic medicine."

First Page Preview View Large
First page PDF preview
First page PDF preview
×